CTRI/2020/09/028107
Recruiting
Phase 2
A Randomized, Active-Controlled, Assessor-Blinded, Parallel Group Clinical Study to compare the Safety and Efficacy of Polyherbal Unani Formulations (O â?? T) with PUVAsol and Mometasone in the Management of Baraá¹£ (Vitiligo)
ational Research Institute of Unani medicine for Skin disorders0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Research Institute of Unani medicine for Skin disorders
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •all age groups from 19 years to 60 years of age
Exclusion Criteria
- •age below 19 years
- •age above 60 years
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
A comparative Clinical Study to evaluate the safety and efficacy of a unani formulation in the Management of Wajaâ??al-MafÄ?á¹£il (Rheumatoid Arthritis)Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecifiedCTRI/2020/03/024187ational Research Institute of Unani Medicine for Skin Disorders Hyderabad
Not yet recruiting
Phase 3
A Phase III clinical study to evaluate efficacy and safety of GeneSys Insulin GlargineCTRI/2023/03/050804GeneSys Biologics Pvt. Ltd.
Not yet recruiting
Phase 2
A clinical research trial to find the safety and effectiveness of asgand and brahmi in underactive thyroid gland functioCTRI/2020/04/024655ational Research Institute of Unani Medicine for Skin Disorders Hyderabad
Active, not recruiting
Phase 1
Study to compare Delafloxacin intravenous and oral single drug therapy with best available treatments in patients with surgical site infectionsAcute Bacterial Skin and Skin Structure InfectionMedDRA version: 20.1Level: PTClassification code 10052891Term: Skin bacterial infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2018-001082-17-ATMENARINI RICERCHE S.p.A.600
Active, not recruiting
Phase 1
Study to compare Delafloxacin intravenous and oral single drug therapy with best available treatments in patients with surgical site infectionsAcute Bacterial Skin and Skin Structure InfectionMedDRA version: 20.1Level: PTClassification code 10052891Term: Skin bacterial infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2018-001082-17-HUMENARINI RICERCHE S.p.A.600